Integra Lifesciences (IART) Stock Price, Quote, News & History | Benzinga

Integra Lifesciences Holdings Corp (IART) Stock Price, Quote, News & History

IARTNASDAQ

Trade with Public

Trade with Public

$16.74

0.150.9%

At close: Aug 20, 5:00 PM EST

$16.91

0.321.93%

Pre-Market: 6:55 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$16.74

Volume / Avg.

70.00 / 916.48K

Day Range

- - -

52 Wk Range

8.70 - 20.49

Market Cap

$1.32B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

11.48%

Days to Cover

5.85

Recent Integra LifeSciences Holdings Corporation News

Rockwell Automation Posts Upbeat Q2 Results, Joins EverQuote, DigitalOcean And Other Big Stocks Moving Higher On Tuesday

Dow Jones up 200 points, Rockwell Automation shares rise 10.8% on strong earnings and raised guidance. Other big gainers include EverQuote, Sterling Infrastructure, and DigitalOcean.

Avi Kapoor

This Parsons Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed outlook on top names. See all rating changes at https://www.benzinga.com/analyst-stock-ratings and analysts' views on PSN.

Avi Kapoor

FDA Issues Alert For Integra Wound Care Products Over Infection Fears

FDA warns of high-risk device issue with wound and burn care products by Integra LifeSciences, citing infection risks.

Vandana Singh

Crude Oil Falls Over 2%; ISM Services PMI Rises In April

Avi Kapoor

Why Is Integra LifeSciences Stock Soaring On Monday?

Integra LifeSciences' Q3 results show adjusted EPS of $0.41 and revenue at $380.83 million. Codman segment grows 1%, while Tissue Tech sees a 3.6% decline.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

85.33M

Investing Cash Flow (TTM)

-108.63M

Financing Cash Flow (TTM)

21.58M

Free Cash Flow (TTM)

11.60M

Capital Expenditure (TTM)

-73.73M

Net Change in Cash (TTM)

-1.72M

Analyst Trends and Forecast

1

Feb

1

Mar

0

0

0

0

Apr

2

1

May

4

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.4

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.08B

PE Ratio (TTM)

-

PE Ratio (FWD)

6.81

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.78

PB Ratio (TTM)

1.25

Earnings Yield % (TTM)

-0.54%

Earnings Yield % (FWD)

14.69%

EV / EBITDA (TTM)

12.55

Price / EBITDA (TTM)

5.25

Price / Free Cash Flow (TTM)

111.07

Book Value / Share

$13.42

Company Debt

Total Debt

$1.87B

LT Debt

$1.83B

LT Debt Issuance (TTM)

$729.30M

LT Debt Repayment (TTM)

-$699.23M

Total Cash

$214.42M

Debt to Equity

1.96

Issuance of Debt (TTM)

$30.07M

Repayment of Debt (TTM)

-$699.23M

Key Statistics

Open

-

Close

$16.74

Volume / Avg.

70.00 / 916.48K

Day Range

- - -

52 Wk Range

8.70 - 20.49

Market Cap

$1.32B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

11.48%

Days to Cover

5.85

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Integra Lifesciences (IART) stock?

A

You can purchase shares of Integra Lifesciences (NASDAQ:IART) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Integra Lifesciences (IART) competitors?

A

Other companies in Integra Lifesciences’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for Integra Lifesciences (IART) stock?

A

Integra Lifesciences has a consensus price target of $22.23.

Q

What is the current price for Integra Lifesciences (IART)?

A

The stock price for Integra Lifesciences (NASDAQ: IART) is $16.91 last updated August 21, 2026 at 6:38 PM EDT.

Q

Does Integra Lifesciences (IART) pay a dividend?

A

There are no upcoming dividends for Integra Lifesciences.

Q

When is Integra Lifesciences (NASDAQ:IART) reporting earnings?

A

Integra Lifesciences does not have any upcoming earnings scheduled.

Q

Is Integra Lifesciences (IART) going to split?

A

There is no upcoming split for Integra Lifesciences.

Q

What sector and industry does Integra Lifesciences (IART) operate in?

A

Integra Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.